Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW MICHAEL BLUMENFELD

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1164459913
CMS profile
324864
Location
CARLSBAD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$558,362.06

563 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $377,673.95 348
H. Lundbeck A S $82,094.58 23
Teva Pharmaceuticals USA, Inc. $31,517.84 49
Lundbeck LLC $24,944.44 51
Bausch Health US, LLC $16,250.00 2
Axsome Therapeutics, Inc. $12,357.92 6
PFIZER INC. $10,434.84 45
Tonix Medicines, Inc. $1,742.61 3
Medtronic, Inc. $500.00 1
Lilly USA, LLC $352.22 16
Impel Pharmaceuticals LLC $81.88 4
Neurelis, Inc. $70.39 3
CSL Behring $57.76 2
Alnylam Pharmaceuticals Inc. $50.40 2
Merz Pharmaceuticals, LLC $49.51 1
Genentech, Inc. $46.78 2
SCILEX PHARMACEUTICALS INC. $43.83 2
Genentech USA, Inc. $33.44 1
Novo Nordisk Inc $32.27 1
Eisai Inc. $27.40 1

Page 4 of 12; records 151–200 of 563 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW MICHAEL BLUMENFELD

NPI 1164459913 · CMS profile ID 324864

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

CARLSBAD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 12; records 151–200 of 563 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164459913?year=2024&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW MICHAEL BLUMENFELD, NPI 1164459913, CMS profile ID 324864. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 12; records 151–200 of 563 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164459913?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ANDREW MICHAEL BLUMENFELD, NPI 1164459913, CMS profile ID 324864. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 12; records 151–200 of 563 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164459913?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ANDREW MICHAEL BLUMENFELD, NPI 1164459913, CMS profile ID 324864, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 12; records 151–200 of 563 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1164459913?year=2024&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

563 matching records · $558,362.06 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 563 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 563.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $3,200.0009/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132149 CMS
ABBVIE INC. $800.0009/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132145 CMS
ABBVIE INC. $800.0009/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132147 CMS
ABBVIE INC. $1,600.0009/04/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132139 CMS
ABBVIE INC. $2,400.0009/04/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132141 CMS
ABBVIE INC. $7,600.0009/04/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132143 CMS
Impel Pharmaceuticals LLC $23.4009/03/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1156153525 CMS
Teva Pharmaceuticals USA, Inc. $15.6109/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151473042 CMS
ABBVIE INC. $15.1508/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103339702 CMS
PFIZER INC. $23.6108/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131885555 CMS
ABBVIE INC. $1,760.0008/23/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132135 CMS
ABBVIE INC. $3,800.0008/23/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132137 CMS
Lilly USA, LLC $27.3908/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135998835 CMS
Teva Pharmaceuticals USA, Inc. $26.6008/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151473032 CMS
Teva Pharmaceuticals USA, Inc. $15.5108/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151473030 CMS
ABBVIE INC. $1,600.0008/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132133 CMS
ABBVIE INC. $15.4808/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103339700 CMS
Lundbeck LLC $1,960.0008/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898532 CMS
PFIZER INC. $12.9908/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131862679 CMS
PFIZER INC. $5.6908/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131878300 CMS
ABBVIE INC. $1,600.0008/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132131 CMS
ABBVIE INC. $5,600.0008/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103141811 CMS
Lundbeck LLC $450.0008/20/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898528 CMS
Lundbeck LLC $4,480.0008/20/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898530 CMS
SCILEX PHARMACEUTICALS INC. $22.8508/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136264640 CMS
ABBVIE INC. $1,600.0008/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132129 CMS
Teva Pharmaceuticals USA, Inc. $1,440.0008/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151473020 CMS
ABBVIE INC. $904.0008/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132125 CMS
ABBVIE INC. $1,600.0008/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132127 CMS
Lundbeck LLC $1.8308/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898524 CMS
Lundbeck LLC $2.6808/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898526 CMS
Lilly USA, LLC $29.2308/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136043332 CMS
PFIZER INC. $26.4508/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131874381 CMS
ABBVIE INC. $1,600.0008/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132123 CMS
ABBVIE INC. $100.0008/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103339698 CMS
ABBVIE INC. $9.1808/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103339696 CMS
ABBVIE INC. $283.5108/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104177746 CMS
ABBVIE INC. $283.5108/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104177748 CMS
Lundbeck LLC $920.0008/07/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898520 CMS
Lundbeck LLC $124.7308/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898522 CMS
Teva Pharmaceuticals USA, Inc. $15.5108/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151473028 CMS
ABBVIE INC. $15.1508/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103339694 CMS
Lundbeck LLC $40.0008/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145898518 CMS
ABBVIE INC. $800.0008/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132121 CMS
ABBVIE INC. $800.0008/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132119 CMS
ABBVIE INC. $28.0307/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103339692 CMS
PFIZER INC. $23.7607/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131748276 CMS
Lilly USA, LLC $32.7907/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136040115 CMS
Lilly USA, LLC $0.7507/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136043328 CMS
PFIZER INC. $3.1007/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131767484 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $892,735.02 1,011
PY2020 $898,849.56 732
PY2021 $855,462.78 891
PY2022 $647,508.80 735
PY2023 $476,664.11 662
PY2024 $558,362.06 563
PY2025 $586,262.38 621

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $148,175.00 25
PY2024 Recipient $3,200.00 1
PY2023 Principal investigator $4,052.73 1
PY2022 Recipient $7,110.00 2
PY2021 Recipient $22.80 1
PY2020 Recipient $3,750.00 1
PY2020 Principal investigator $34.83 1
PY2019 Principal investigator $78.27 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $600.00 12/31/2025 Non-covered Recipient Entity
LISA G COOK MD INC
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine with an Open-Label Extension No dispute reported 06/30/2026 1202534255
Principal investigator 1 ABBVIE INC. $6,367.50 12/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202526820
Principal investigator 1 ABBVIE INC. $1,620.00 12/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202526902
Principal investigator 1 ABBVIE INC. $7,582.50 11/05/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202522741
Principal investigator 1 ABBVIE INC. $16,368.75 11/05/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202522743
Principal investigator 1 ABBVIE INC. $11,272.50 10/09/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202514087
Principal investigator 1 ABBVIE INC. $9,483.75 10/09/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202514089
Principal investigator 1 Merz Pharmaceuticals, LLC $2,000.00 10/08/2025 Non-covered Recipient Entity
LISA COOK MD INC
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin Injections for Preventing Chronic Migraine No dispute reported 06/30/2026 1232647406
Principal investigator 1 Merz Pharmaceuticals, LLC $15,000.00 10/08/2025 Non-covered Recipient Entity
LISA COOK MD INC
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin Injections for Preventing Chronic Migraine No dispute reported 06/30/2026 1232647412
Principal investigator 1 ABBVIE INC. $2,966.25 09/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202509230
Principal investigator 1 ABBVIE INC. $1,620.00 09/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202509232
Principal investigator 1 ABBVIE INC. $6,041.25 08/06/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202503503
Principal investigator 1 ABBVIE INC. $6,150.00 07/08/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202497054
Principal investigator 1 ABBVIE INC. $1,800.00 07/02/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202494275
Principal investigator 1 ABBVIE INC. $14,985.00 07/02/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202494277
Principal investigator 1 ABBVIE INC. $4,792.50 06/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202487931
Principal investigator 1 ABBVIE INC. $2,666.25 06/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202487933
Principal investigator 1 ABBVIE INC. $1,485.00 05/07/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202483201
Principal investigator 1 ABBVIE INC. $2,261.25 05/07/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202483203
Principal investigator 1 ABBVIE INC. $1,620.00 04/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202469059
Principal investigator 1 ABBVIE INC. $7,796.25 04/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202469230
Principal investigator 1 ABBVIE INC. $6,986.25 03/07/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202459627
Principal investigator 1 ABBVIE INC. $3,105.00 02/06/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202449758
Principal investigator 1 ABBVIE INC. $10,500.00 01/28/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
P24-880 - Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202441700
Principal investigator 1 ABBVIE INC. $3,105.00 01/02/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202436107